Broadwood Capital Inc 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Broadwood Capital Inc disclosed 8 US equity positions worth $1.5bn in its Q2 2025 13F filing. The largest position was AXON at 37.4% of the reported book, followed by MNST and STAA. Against the Q1 2025 filing, it opened 0 new positions, added to 2 and reduced 0 among the top 8 holdings.
What did Broadwood Capital Inc own in Q2 2025? Top 8 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | AXON AXON ENTERPRISE INC | Industrials | 37.4% | $574.8m | 694,264 | -0% | held |
| 2 | MNST MONSTER BEVERAGE CORP NEW | Consumer Defensive | 33.7% | $517.1m | 8,255,428 | -0% | held |
| 3 | STAA STAAR SURGICAL CO | Healthcare | 14.8% | $226.9m | 13,519,491 | 9% | added |
| 4 | IWM ISHARES TR | 6.7% | $102.5m | 474,920 | 0% | held | |
| 5 | LCTX LINEAGE CELL THERAPEUTICS IN | 2.9% | $45.0m | 49,560,992 | 0% | held | |
| 6 | IMDX INSIGHT MOLECULAR DIA INC | 2.2% | $34.5m | 11,410,100 | 0% | held | |
| 7 | OLOGBX OLO INC | 2.2% | $33.7m | 3,782,821 | 112% | added | |
| 8 | SERINA THERAPEUTICS INC | 0.0% | $524.9k | 85,219 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.